D
David S.K. Lu
Researcher at University of California, Los Angeles
Publications - 204
Citations - 12768
David S.K. Lu is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Hepatocellular carcinoma & Magnetic resonance imaging. The author has an hindex of 54, co-authored 193 publications receiving 11283 citations. Previous affiliations of David S.K. Lu include University of California, Davis & UCLA Medical Center.
Papers
More filters
Journal ArticleDOI
Image-guided Tumor Ablation: Standardization of Terminology and Reporting Criteria—A 10-Year Update
Muneeb Ahmed,Luigi Solbiati,Christopher L. Brace,David J. Breen,Matthew R. Callstrom,J. William Charboneau,Min-hua Chen,Byung Ihn Choi,Thierry de Baere,Gerald D. Dodd,Damian E. Dupuy,Debra A. Gervais,David Gianfelice,Alice Gillams,Fred T. Lee,Edward Leen,Riccardo Lencioni,Peter Littrup,T. Livraghi,David S.K. Lu,John P. McGahan,Maria Franca Meloni,Boris Nikolic,Philippe L. Pereira,Ping Liang,Hyunchul Rhim,Steven C. Rose,Riad Salem,Constantinos T. Sofocleous,Stephen B. Solomon,Michael C. Soulen,Masatoshi Tanaka,Thomas J. Vogl,Bradford J. Wood,S. Nahum Goldberg +34 more
TL;DR: This updated consensus document provides a framework that will facilitate the clearest communication among investigators regarding ablative technologies and improve the precision of communications in this field, leading to more accurate comparison of technologies and results, and ultimately to improved patient outcomes.
Journal ArticleDOI
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer.
Howard I. Scher,David S.K. Lu,Nicole A. Schreiber,Jessica Louw,Ryon P. Graf,Hebert Alberto Vargas,Ann Johnson,Adam Jendrisak,Richard Martin Bambury,Daniel C. Danila,Daniel C. Danila,Brigit McLaughlin,Justin Wahl,Stephanie B. Greene,Glenn Heller,Dena Marrinucci,Martin Fleisher,Ryan Dittamore +17 more
TL;DR: CTC nuclear expression of AR-V7 protein in men with mCRPC is validated as a treatment-specific biomarker that is associated with superior survival on taxane therapy over ARS-directed therapy in a clinical practice setting.
Journal ArticleDOI
Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.
TL;DR: A grading system for tumor involvement of the major vessels in patients with pancreatic adenocarcinoma can be based on the degree of circumferential contiguity of tumor to vessel.
Journal ArticleDOI
Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect.
TL;DR: There appears to be a narrow transition zone for hepatic vessels at 2-4 mm, beyond which the heat sink effect was seen consistently and substantial vascular injury was rare.
Journal ArticleDOI
Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors.
David S.K. Lu,Steven S. Raman,Piyaporn Limanond,Donya Aziz,James S. Economou,Ronald W. Busuttil,James Sayre +6 more
TL;DR: Multivariate logistic regression analysis showed that presence or absence of a large peritumoral vessel is an independent, and the dominant, predictor of treatment outcome of incomplete tumor destruction by RF ablation.